eazyplex® STDs

Product code: E7640 (Complete), E7641 (CT), E7642 (CT/NG)
Producer: AmplexDiagnostics GmbH
Obrazek produktu - eazyplex® STDs
Rapid molecular diagnostic kits for the direct detection of the most common bacterial sexually transmitted infections (STIs) directly from swab samples — without the need for DNA extraction.

More detailed product information

The eazyplex® STD portfolio includes several assay formats that allow flexible testing based on clinical needs:

  • eazyplex® STD complete — detects multiple bacterial STI pathogens in one panel

  • eazyplex® STD CT/NG — detects Chlamydia trachomatis and Neisseria gonorrhoeae

  • eazyplex® STD CT — detects Chlamydia trachomatis only

All kits are ready-to-use and lyophilized, and they include all required buffers and reagents. Clinical swab samples (e.g., urethral, rectal/anal, vaginal, cervical, or pharyngeal) can be processed in about 3 minutes and loaded directly into the test.


 

Detectable Pathogens

Depending on the kit chosen, eazyplex® STDs can detect the following bacterial pathogens from swab samples:

  • Chlamydia trachomatis

  • Neisseria gonorrhoeae

  • Ureaplasma urealyticum

  • Mycoplasma hominis

  • Mycoplasma genitalium

  • Treponema pallidum


 

How It Works

  • Based on LAMP (Loop-Mediated Isothermal Amplification) technology for rapid nucleic acid detection

  • No DNA extraction required — simplifies workflow

  • Approx. 25 min from sample to result

  • Real-time amplification measurement

  • Includes internal controls to prevent false-negative results and verify sample adequacy (e.g., human β-globin control)


 

Key Benefits

  • Rapid turnaround time — results in about 25 minutes

  • Direct testing from swab samples

  • Flexible panel options based on clinical needs

  • All reagents included for ease of use

  • Supports timely clinical decision-making and treatment initiation


 

Intended Use

The eazyplex® STDs assays are intended for clinical microbiology laboratories and point-of-care settings as an aid in the diagnosis and screening of common bacterial sexually transmitted infections. Early detection and reporting enable:

  • Prompt initiation of appropriate therapy

  • Reduction in further transmission

  • Improved patient management

Timely diagnosis is particularly important because untreated STIs can lead to complications such as infertility, ectopic pregnancy, adverse pregnancy outcomes, and increased risk of transmission.


For more information, please contact us by e-mail: diagnostika@pentagen.cz